Biotech Archives - Page 729 of 733

2 minute read

Vertex Announces Letter Of Intent With The pan-Canadian Pharmaceutical Alliance For Public Reimbursement Of TRIKAFTA in Children With Cystic Fibrosis Ages 6 And Older

July 7, 2:28 PM

Vertex Pharmaceuticals Incorporated (Canada) (NASDAQ:VRTX) today announced that it has signed a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA), which represents an agreement in principle

VRTX

2 minute read

Elon Musk, You’re Cordially Invited To The Benzinga Cannabis Capital Conference In Chicago, No Need To RSVP, See You There?

By Maureen Meehan

July 7, 11:10 AM

If Tesla (NASDAQ: TSLA) CEO Elon Musk had not been having an ‘excruciating’ year, he might have had the good fortune to attend the very first Benzinga Cannabis Capital Conference in Toronto in April 2018.

TSLA

1 minute read

Galmed’s Aramchol Shows Anti-Fibrotic Effects In Lung Fibrosis Animal Model

By Vandana Singh

July 7, 10:18 AM

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) announced results showing significant effects of Aramchol in a preclinical lung and gastrointestinal (GI) fibrosis model. Treatment…

GLMD

3 minute read

The Daily Biotech Pulse: Merck’s Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill

By Vandana Singh

July 7, 10:03 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADVM

1 minute read

Verve Therapeutics Amends Gene Editing Pact With Beam Therapeutics

By Vandana Singh

July 7, 8:28 AM

Verve Therapeutics Inc (NASDAQ:VERV) entered into an Amended and Restated Collaboration and License Agreement with Beam Therapeutics Inc (NASDAQ:BEAM), which amended…

BEAM

2 minute read

Kiromic BioPharma Announces Completion Of Expanded cGMP Manufacturing Facility To Support Cell Therapy Oncology Pipeline

By Bill Haddad

July 7, 8:20 AM

Construction Completion is One of the Pre-requisites to Beginning the Deltacel™ Clinical Trial Activation Later This Year and Addresses a Key Clinical Hold Citation Kiromic BioPharma, Inc. (NASDAQ:KRBP)

KRBP

1 minute read

Adverum Biotechnologies Cuts Workforce, Prioritizes ADVM-022

By Vandana Singh

July 7, 8:02 AM

Adverum Biotechnologies Inc (NASDAQ:ADVM) announced a restructuring plan, including reductions in headcount and expenses, to prioritize its clinical development of…

ADVM

1 minute read

Senate Finance Committee Probe Reveals How AbbVie Exploits Offshore Subsidiaries To Avoid Tax Bills

By Vandana Singh

July 7, 7:46 AM

Provisions in the 2017 Republican tax law allow AbbVie Inc (NYSE: ABBV) to generate most of its sales in the U.S. while reporting virtually no income in the U.S. for tax purposes.

ABBV

1 minute read

Portage Biotech Bolsters Pipeline With Acquisition Of Four Adenosine Pathway-Targeting Candidates

By Vandana Singh

July 7, 6:58 AM

Portage Biotech Inc (NASDAQ:PRTG) has agreed to acquire Tarus Therapeutics, a private company developing adenosine receptor antagonists. Under the terms of…

PRTG

1 minute read

Adverum Biotechnologies Completes IND Amendment And Prepares To Initiate The Phase 2 LUNA Trial Of ADVM-022 In Wet AMD

By Benzinga Newsdesk

July 6, 4:10 PM

- Cash runway extended into 2025 due to corporate restructuring to prioritize the clinical development of ADVM-022 and provide additional resources beyond anticipated one-year topline results of the Phase 2 LUNA trial -

ADVM